The representative body of the US Biotechnology industry, BIO, has joined PhRMA in criticising President Donald Trump's executive order directing administration officials to secure the 'Most Favored Nation' pharmaceutical pricing.
US BIO joins PhRMA in challenging Trump over 'Most Favored Nation' order
May 14, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Wesfarmers Health acquires Pharmacy 4 Less group
June 4, 2025 - - Latest News -
Cannabis Council Australia appoints CEO to lead next phase of industry reform
June 4, 2025 - - Latest News -
AusBiotech and Austrade launch partnership to accelerate global expansion of life sciences industry
June 4, 2025 - - Latest News -
Jordan Steele-John reappointed to represent Greens in health portfolio
June 4, 2025 - - Latest News -
Arrotex launches newly developed treatment for Australians with common skin conditions on the PBS
June 3, 2025 - - Latest News -
BMS Australia celebrates silver tier employer status at Australian LGBTQ+ Inclusion Awards
June 3, 2025 - - Latest News -
Sandoz calls for reforms to unlock biosimilar savings
June 3, 2025 - - Latest News